References
1. Blaster MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL. Infections of the gastrointestinal tract 2002. 2nd edth ed. Philadelphia: www; 1241–1250.
3. DuPont HL. The Practice Parameters Committee of the American College of Gastroenterology. Gudelines on acute infectious diarrhea in adults. Am J Gastroenterol 1997. 921962–1975.
4. Duggan C, Santosham M, Glass RI. Centers for Disease Control and Prevention. The management of acute diarrhea in children: Oral rehydration, maintenance, and nutritional therapy. Morb Mortal Wkly Rep 1992. 411–20.
5. Cohen J, Powderly WG. Infectious diseases 2004. 2nd edth ed. Spain: Elsvier; 1445–1451.
6. Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part III: travelers' diarrhea. J Travel Med 2002. 9141–150.
7. Ericsson CD, DuPont HL, Mathewson JJ, West MS, Johnson PC, Bitsura JA. Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA 1990. 263257–261.
8. Swedish study group. Empiric treatment of acute diarrheal disease with norfloxacin: a randomized, placebo controlled study. Ann Intern Med 1992. 117202–208.
9. Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med 1992. 117297–302.
10. Zhang XP, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DK. Quinolone antibiotics induce Shiga toxinencoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000. 181664–670.
11. Bennish ML, Salam MA, Haider R, Barza M. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 1990. 162711–716.
12. Salazar-Lindo E, Sack RB, Chea-Woo E, Kay BA, Piscoya ZA, Leon-Barua R, Yi A. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr 1986. 109355–360.
13. Thielman NM, Guerrant RL. Acute infectious diarrhea. N Engl J Med 2004. 35038–47.
14. Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001. 32331–351.
15. Shin HB, Jeong SH, Kim M, Kim WH, Lee K, Chong Y. Isolation trend of enteropathogenic bacteria in 1969-1998. Korean J Clin Microbiol 2001. 487–95.
16. Lee JC, Oh JY, Kim KS, Jeong YW, Cho JW, Park JC, Seol SY, Cho DT. Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 2001. 109228–234.
17. Pai H, Choi E, Lee H, Hong J, George A. Jacob: dentification of CTX-M-14 extended-spectrum bata-lactamase in clinical isolates of Shigella sonnei, Escherichia coli and Klebsiella pneumoniae in Koera. J Clin Microbiol 2001. 393747–3749.
18. Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Pediatr Infect Dis J 2002. 211136–1141.
19. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerg Infect Dis 2002. 81501–1503.